---
title: "OMENN GILBERT S — Ownership Dossier"
canonical: https://whiteintel.dev/entity/21bef5fd-f0c5-598d-ab10-eade274d0e5a
json: https://whiteintel.dev/api/public/dossier/21bef5fd-f0c5-598d-ab10-eade274d0e5a
identifier: sec:0001184227
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# OMENN GILBERT S

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001184227`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/21bef5fd-f0c5-598d-ab10-eade274d0e5a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/21bef5fd-f0c5-598d-ab10-eade274d0e5a  

## Ownership & control

### Holdings / subsidiaries

- **Amesite Inc.** (director) — https://whiteintel.dev/entity/4a720be1-85a5-59fa-8f81-6c4a056493db
- **GALECTIN THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/f8080f77-4e50-5fe6-9c7b-cf0486465d72
- **GALECTIN THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/f8080f77-4e50-5fe6-9c7b-cf0486465d72
- **Amesite Inc.** (director) — https://whiteintel.dev/entity/4a720be1-85a5-59fa-8f81-6c4a056493db
- **Amesite Inc.** (director) — https://whiteintel.dev/entity/4a720be1-85a5-59fa-8f81-6c4a056493db
- **Amesite Inc.** (director) — https://whiteintel.dev/entity/4a720be1-85a5-59fa-8f81-6c4a056493db
- **ROHM & HAAS CO** (director) — https://whiteintel.dev/entity/eb3aa500-530c-53a6-bba7-a219fb7daeeb
- **AMGEN INC** (director) — https://whiteintel.dev/entity/2df541d6-6f5e-5de3-8f54-0253cab77f19
- **Amesite Inc.** (director) — https://whiteintel.dev/entity/4a720be1-85a5-59fa-8f81-6c4a056493db
- **GALECTIN THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/f8080f77-4e50-5fe6-9c7b-cf0486465d72
- **Elicio Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/6920dd23-e8fa-5955-be4f-bd9b8ecc8c89
- **AMESITE INC.** (director) — https://whiteintel.dev/entity/6228a133-bd75-5954-ae4f-b2eee7fcd24b
- **Esperion Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/81cbdfd2-e186-5143-8c51-21506a65d822
- **OCCULOGIX, INC.** (director) — https://whiteintel.dev/entity/39d69da8-06df-5ef1-8be1-f641f4fe0ec1

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **OMENN GILBERT S**. Human view: https://whiteintel.dev/entity/21bef5fd-f0c5-598d-ab10-eade274d0e5a · Structured JSON: https://whiteintel.dev/api/public/dossier/21bef5fd-f0c5-598d-ab10-eade274d0e5a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._